Bichette's All-Star Break Sits, but His Mets Lineup Crush Carries Weight

Bo Bichette sat out his second consecutive game Saturday as the Mets faced the Red Sox, with manager Andy Green signaling the infielder may not return until after the All-Star break concludes. The 51-year-old third baseman and shortstop hybrid absorbed cumulative leg damage during Atlanta's series last weekend—fouling balls into his shins while going 8-for-18—and the soreness has paired with right ankle inflammation to make him a scratch through at least Tuesday's Midsummer Classic window.

The timing creates a roster puzzle for New York, but it masks a more consequential offensive arc. Bichette's recent stretch—.320 with two homers and 11 RBIs over his last 25 games—traces a player who'd climbed out of an 2-for-22 open and a .219 first-two-months crater. The Mets signed him to a $126 million three-year deal in mid-January as their third-base anchor, and even while Francisco Lindor recovered from a calf strain, Bichette's bat has found its footing. The concern for the organization is visibility: a seven-day absence (All-Star break games are July 15-16, with travel and reset eating into the 13th-14th) interrupts momentum right when the second half demands it.

For bettors, the near-term impact is surgical. With Bichette unavailable and Marcus Semien (acquired for Brandon Nimmo in November) still weeks away from a rehab assignment after his June 25 placement on the 10-day IL for a left hip flexor strain, the Mets' infield depth takes a hit. Semien, batting .214 with nine homers and 29 RBIs across 80 games, is a secondary source of power, not a carry. The loss of Bichette's recent bat speed—reinforced by the $126M investment the franchise is banking on—tilts the aggregate run-production calculus. New York's team total odds at sportsbooks currently price their run output assuming full roster availability; sudden absences of a player hitting .320 over a rolling sample don't recalibrate instantly.

This is a fade-overs spot. The Mets are a team built on Lindor's base (now healthy) and Bichette's tertiary power, minus the one guy who just proved he could deliver. Until Bichette returns post-break and the lineup reconstitutes, team totals above 4.0 in games through July 13 carry inflated run expectations. The market hasn't yet absorbed how much offensive capacity walks out with him through Tuesday.